Amity Mahoney, PA
Surgical · Lees Summit, MONPI 1831730241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 65.2% of it on its own, with 6 other manufacturers making up the rest.
Across 56 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$718
- Ferring Pharmaceuticals Inc.$149
- Smith+Nephew$89
- Polynovo North America LLC$61
- Vertex$36
- Pacira Pharmaceuticals Incorporated$25
- plus $24 from 1 others
What the payments were for
- Food & beverage$1,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 39 | $718 |
| Ferring Pharmaceuticals Inc. | 8 | $149 |
| Smith+Nephew | 3 | $89 |
| Polynovo North America LLC | 2 | $61 |
| Vertex | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Bioventus LLC | 1 | $24 |
How this compares
$1,102 in reported general payments places this provider in the 75th percentile of 118 surgical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 38 | $21,372 |
| Enoxaparin Sodium | 26 | $4,419 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $1,006 |
| Gabapentin | 139 | $670 |
| Tizanidine Hcl | 140 | $665 |
| Meloxicam | 168 | $325 |
| Doxycycline Hyclate | 27 | $278 |
| Ondansetron OdtOndansetron | 26 | $173 |
| Cyclobenzaprine Hcl | 15 | $123 |
| Metoclopramide Hcl | 42 | $80 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other surgical in Lees Summit
- Jessica CullenLees Summit$695
- Ciara GlennSaint Louis$9K
- Chad NallSpringfield$6K
- Thomas PrangeSaint Louis$5K
- Lia GauseLiberty$4K
- Frances AbbiattiSpringfield$3K
- Drew CottrillSaint Joseph$3K
- Chad OliverSpringfield$3K
- Sigal FridmanSaint Louis$3K
- Ella BarberSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.